Xspray Pharma AB (publ)
SSE:XSPRAY.ST
44 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0.277 | 0.332 | 0.792 | 3.64 |
| Cost of Revenue
| 9.194 | 9.532 | 8.87 | 1.411 | 4.803 | 0 | -4.135 | -6.193 | 5.294 |
| Gross Profit
| -9.194 | -9.532 | -8.87 | -1.411 | -4.803 | 0.277 | 4.466 | 6.985 | -1.654 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 1 | 13.471 | 8.819 | -0.454 |
| Reseach & Development Expenses
| 40.259 | 22.219 | 38.567 | 6.549 | 3.429 | 5.536 | 3.354 | 0 | 0 |
| General & Administrative Expenses
| 0 | 109.601 | 58.384 | 47.101 | 42.327 | 0 | 8.618 | 3.771 | 4.274 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 16.967 | 0 | 0 | 0 |
| SG&A
| 169.567 | 109.601 | 58.384 | 47.101 | 42.327 | 16.967 | 8.618 | 3.771 | 4.274 |
| Other Expenses
| 0 | -0.438 | 0 | -0.005 | 0 | 0.414 | 9.145 | 7.274 | 6.162 |
| Operating Expenses
| 181.734 | 131.382 | 96.951 | 53.645 | 45.756 | 22.917 | 17.762 | 11.045 | 10.436 |
| Operating Income
| -180.765 | -133.073 | -97.953 | -53.457 | -45.705 | -23.217 | -13.278 | -4.059 | -12.088 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | -83.816 | -40.048 | -5.125 | -3.321 |
| Total Other Income Expenses Net
| 1.081 | 1.403 | 1.255 | 1.047 | -0.066 | -0.458 | 0.098 | -0.037 | -0.001 |
| Income Before Tax
| -179.684 | -131.67 | -96.698 | -52.41 | -45.771 | -23.098 | -13.198 | -4.097 | -12.091 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | -83.386 | -39.809 | -5.173 | -3.322 |
| Income Tax Expense
| 0.017 | -1.403 | 0.004 | -0.107 | 0.066 | -0.427 | 0.098 | 0.022 | 0.002 |
| Net Income
| -179.667 | -130.267 | -96.702 | -52.303 | -45.837 | -23.098 | -13.198 | -4.097 | -12.091 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | -83.386 | -39.809 | -5.173 | -3.322 |
| EPS
| -6.76 | -6.13 | -4.98 | -3.01 | -2.99 | -1.68 | -1.65 | -0.64 | -0.97 |
| EPS Diluted
| -6.76 | -6.13 | -4.98 | -3.01 | -2.99 | -1.63 | -1.56 | -0.33 | -0.97 |
| EBITDA
| -174.272 | -122.125 | -87.824 | -44.828 | -40.902 | -18.892 | -12.032 | -3.373 | -11.48 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | -68.202 | -36.29 | -4.259 | -3.154 |